who _ intermittent preventive treatment in pregnancy (iptp)

2/28/2016 WHO | Intermittent preventive treatment in pregnancy (IPTp) http://www.who.int/malaria/areas/preventive_therapies/pregnancy/en/ 1/2 Malaria Intermittent preventive treatment in pregnancy (IPTp) Malaria infection during pregnancy is a major public health problem, with substantial risks for the mother, her fetus and the neonate. Intermittent preventive treatment of malaria in pregnancy is a full therapeutic course of antimalarial medicine given to pregnant women at routine prenatal visits, regardless of whether the recipient is infected with malaria. IPTp reduces maternal malaria episodes, maternal and fetal anaemia, placental parasitaemia, low birth weight, and neonatal mortality. Read more on malaria in pregnant women WHO recommendations WHO recommends IPTp with sulfadoxinepyrimethamine (IPTpSP) in all areas with moderate to high malaria transmission in Africa. As of October 2012, WHO recommends that this preventive treatment be given to all pregnant women at each scheduled antenatal care visit except during the first trimester. WHO recommends a schedule of four antenatal care visits. Based on currently available evidence, the preventive efficacy of SP for IPTp persists even in areas where quintuple mutations linked to SP resistance are prevalent in P. falciparum. Low uptake of IPTp in some African countries Among the approximately 840 million persons at risk of malaria in endemic countries in subSaharan Africa, an estimated 35 million pregnant women could benefit from IPTp each year. However, during the last few years, WHO has observed a declining effort to scaleup IPTp in a number of African countries. In highburden countries, IPTp noticeably lags behind other malaria control measures. This does not appear to be due to low levels of antenatal clinic attendance. Uncertainty among health workers about SP administration for IPTp may have also played a role. Simplified IPTp messages and health worker training have been shown to improve IPTp coverage. Last update: 20 February 2015 Key documents WHO policy brief for the implementation of intermittent preventive

Upload: mithlesh-dewangan

Post on 14-Jul-2016

217 views

Category:

Documents

3 download

Report

Download

Embed Size (px):

DESCRIPTION

prventive treatment of malaria

TRANSCRIPT

Page 1: WHO _ Intermittent Preventive Treatment in Pregnancy (IPTp)

2/28/2016 WHO | Intermittent preventive treatment in pregnancy (IPTp)

http://www.who.int/malaria/areas/preventive_therapies/pregnancy/en/ 1/2

MalariaIntermittent preventive treatment inpregnancy (IPTp)Malaria infection during pregnancy is a major public health problem, withsubstantial risks for the mother, her fetus and the neonate. Intermittentpreventive treatment of malaria in pregnancy is a full therapeutic courseof antimalarial medicine given to pregnant women at routine prenatalvisits, regardless of whether the recipient is infected with malaria. IPTpreduces maternal malaria episodes, maternal and fetal anaemia,placental parasitaemia, low birth weight, and neonatal mortality.